Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.49
-0.15 (-2.66%)
Jan 2, 2026, 10:21 AM EST - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $427.73 million as of January 2, 2026. Its market cap has increased by 118.03% in one year.
Market Cap
427.73M
Enterprise Value
225.21M
1-Year Change
118.03%
Ranking
Category
Stock Price
$5.49
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $427.73M, a decrease of -94.14%. That is a compound annual growth rate of -30.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 439.41M | 174.95% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |